Home >> Research >> Achievements >> Content

West China Hospital Wins International Recognition For the First Percutaneous Transhepatic Route for Cardiac Resynchronization Therapy

Date:Jun 3, 2019

The West China Hospital research team of Yuan Fang, Hongde Hu and Bo Wei has published a case study “Percutaneous transhepatic route for cardiac resynchronization therapy in a patient with superior vena cava occlusion” in Europace, an authoritative periodical in cardiac pacing. The publication indicates that this innovative operation therapy has won international recognition, meaning that West China Hospital is the world leader in finding new safe and effective pacemaker implantation pathways. The first author is Hongde Hu, Department of Cardiology, the corresponding author is Yuan Fang. The second author is Bo Wei, Department of Digestive Medicine, and SCU West China (Huaxi) Hospital is the first work unit.

说明: http://www.scu.edu.cn/__local/A/82/9C/6195D70D43EC33C86CE46812402_EE1CD170_1D4D7.jpg

Conventional pacemaker electrode implantation pathway is to puncture the superior thoracic vein under local anesthesia. Subclavian or axillary veins are often selected to enter the cardiac cavity through the superior vena cava. If the patient has severe stenosis or occlusion of the superior vena cava or has undergone anastomosis between the superior vena cava and the right pulmonary artery due to congenital heart disease, the pacemaker electrode cannot be implanted through the above routine pathway. Therefore, pacemaker implantation in these patients needs to find a new safe and effective implantation path.

In 2012, the Department of Cardiology of West China Hospital successfully completed the world's first ICD implantation via hepatic vein pathway. In 2013, the world's second case / the country's first case of double chamber pacemaker implantation via hepatic vein pathway was completed. In 2017, the first anti-heart failure pacemaker CRT was implanted via hepatic vein pathway. In 2018, CRTD, the first anti-heart failure defibrillator in the world, was implanted via hepatic vein pathway. All the above patients are in good condition at present, which indicates that pacemaker implantation via hepatic vein pathway is safe and effective.

Article link:  https://www.escardio.org/Education/E-Learning/Clinical-cases/Electrophysiology

On a:SCU Alumna Tan Li Has Made It to Forbes Women in Tech List.

The next article:SCU West China School / Hospital of Stomatology SCU Tops the Nature Index in Dentistry

Shut down




© 2020 World-Class University Development Office